Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study'. Together they form a unique fingerprint.
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science